DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
6th Annual Chicago Sickle Cell Summit
Date & Time
Sep 28, 2023 11:00 AM in Eastern Time (US and Canada)
Description
The theme for this year’s summit is “Thriving with Sickle Cell Disease: Optimizing Care Through all Stages of Life.”
The goal is to highlight the latest trends, successes, challenges, and barriers to propel the lives of the Sickle Cell community beyond survival/sustenance to thriving.
The goal is to highlight the latest trends, successes, challenges, and barriers to propel the lives of the Sickle Cell community beyond survival/sustenance to thriving.
Keynote speaker: Wanda Whitten-Shurney, CEO and Medical Director of SCDAA-MI
Session 1: Genetics and Foundations of Care Featured speakers – Kay Saving, Marwah Farooqui, Lewis Hsu
Session 2: Emerging Care, Medicines, and Treatments Featured speakers – Franklin Njoku, Damiano Rondelli, Joseph Colla
Session 3: Building Community Partnerships through Training
We are offering a maximum of 4 CE credits for providers. Please indicate your request for credits in the exit survey.
The summit is free for all participants.
Share
+myBinderRelated Content
-
news & eventsHospitals See No Link Between US Opioid Crisis and Patients’ Use of Treatment, Study ReportsThe U.S. opioid epidemic is not linked t...
-
people & placesRaymona Lawrence, DPHDr. Raymona Lawrence serves as the Direc...
-
education & researchThe influence of the age of adults with sickle cell disease on the uptake, utilization and efficacy of HydroxyureaDespite the efficacy of Hydroxyurea (HU)...
-
news & eventsFDA Approves First Targeted Therapy to Treat Patients with Painful Complication of Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
-
education & researchAssociation Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients With Sickle Cell Disease: A Retros...Background/Objectives: Among sickle cel...
-
news & eventsEmmaus Life Sciences, Inc. to present results of phase 3 study of endariTM (L-glutamine oral powder) at 59th America...Emmaus will present results of a Phase 3...
-
videos & visualsDeveloping Hydroxyurea, the First FDA-Approved Therapy for Sickle Cell Diseasehttps://www.youtube.com/watch?v=0kIz5ZKy...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.